Erratum: MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo (Cell Stem Cell (2019) 24(4) (579–591.e12), (S193459091930013X), (10.1016/j.stem.2019.01.013))

Lorna R. Fiedler, Kathryn Chapman, Min Xie, Evie Maifoshie, Micaela Jenkins, Pelin Arabacilar Golforoush, Mohamed Bellahcene, Michela Noseda, Dörte Faust, Ashley Jarvis, Gary Newton, Marta Abreu Paiva, Mutsuo Harada, Daniel J. Stuckey, Weihua Song, Josef Habib, Priyanka Narasimhan, Rehan Aqil, Devika Sanmugalingam, Robert YanLorenzo Pavanello, Motoaki Sano, Sam C. Wang, Robert D. Sampson, Sunthar Kanayaganam, George E. Taffet, Lloyd H. Michael, Mark L. Entman, Tse Hua Tan, Sian E. Harding, Caroline M.R. Low, Catherine Tralau-Stewart, Trevor Perrior, Michael D. Schneider

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

(Cell Stem Cell 24, 579–591.e1–e12; April 4, 2019) In the originally published version of our manuscript, one of the authors was incorrectly listed as “Narasimham, P.” To address this, we have now corrected the spelling of the name both here and in our original article online to “Narasimhan, P.” We apologize for the oversight and for any resulting confusion.

Original languageEnglish (US)
Pages (from-to)458
Number of pages1
JournalCell Stem Cell
Volume26
Issue number3
DOIs
StatePublished - Mar 5 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Erratum: MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo (Cell Stem Cell (2019) 24(4) (579–591.e12), (S193459091930013X), (10.1016/j.stem.2019.01.013))'. Together they form a unique fingerprint.

Cite this